<DOC>
	<DOCNO>NCT01974648</DOCNO>
	<brief_summary>The aim study determine clinically required concentration propofol LMA Supreme insertion , examine extent remifentanil reduces dose propofol improves condition 's insertion .</brief_summary>
	<brief_title>Propofol Supreme LMA Insertion With Without Remifentanil</brief_title>
	<detailed_description>The single-use Laryngeal Mask Airway SupremeTM ( SLMA , Laryngeal Mask Company Limited , Singapore ) new single use supraglottic airway device introduce recently present combined feature LMA ProSealTM ( PLMA , Laryngeal Mask Company Limited ) LMA FastrachTM ( FLMA , Laryngeal Mask Company Limited ) . The mask anatomically shape airway tube , elliptical cross-section facilitates easy insertion minimize accidental rotation . The cuff bowl design prevent airway kink offer high airway seal pressure around laryngeal opening LMA ClassicTM ( CLMA , Laryngeal Mask Company Limited ) It drain tube provide functional separation respiratory digestive tract prevent gastric aspiration . Even though insertion SLMA associate high initial success rate , few airway manipulation safe effective airway anaesthesia , anaesthetic technique insertion standardise . Most available data requirement anaesthetic drug co-induction agent use insertion SLMA originate research involve assessment SLMA seal respiratory gastrointestinal tract.We test difference predict concentration propofol without remifentanil insertion SLMA . Methods : 50 patient ASA class I II age 18-75 year undergo ambulatory elective surgery randomize one two group : receive propofol + saline ( control group : n = 25 ) propofol + remifentanil ( propofol-remifentanil group : n=25 ) . We use target-controled infusion ( Alaris®PK ) drug : propofol ( Marsh et al.´s pharmacokinetic model ) remifentanil ( Minto et al.´s pharmacokinetic model ) . The patient wil premedicated midazolam 1 mg iv surgery . The target concentration patient determine use Dixon´s up-and-down method . Predetermined propofol remifentanil blood effect site concentration hold constant least 10 min . After equilibration plasma effect site propofol concentration , SLMA insert , secure accord manufacture´s recommendation , without use muscle relaxant . In control group , propofol concentration start 4 μg ml-1 , 0,5 μg ml-1 step size , coadministration saline . In propofol-remifentanil group , propofol + remifentanil target-controlled infusion 5 ng/mL coadministered . A single measurement obtain patient . If patient react movement , propofol concentration next patient increase 0.5 μg ml-1 ±1 ; movement , decrease 0.5 μg ml-1 ±1 . Movement define buck gross purposeful muscular movement within 1 min LMA insertion . Values Cp 50 wil determine calculate midpoint concentration least seven crossover point ( movement/non movement ) obtain group .</detailed_description>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<criteria>ASA IIII patient Scheduled ambulatory surgery Need general anaesthesia General anaesthesia usually perform laryngeal mask Negative pregnancy test woman . Signed informed consent . Patients potentially difficult airway ( Mallampati III IV , limit mouth open and/or cervical spine disease ) Patients reactive airway disease Signs upper respiratory infection , Patients risk gastric aspiration</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Laryngeal Mask Airway Supreme</keyword>
	<keyword>propofol</keyword>
	<keyword>remifentanil</keyword>
	<keyword>effective dose intravenous propofol</keyword>
	<keyword>ED50</keyword>
</DOC>